Latest Breaking News On - Sinopharm china national pharmaceutical group - Page 1 : comparemela.com

Situation Update: Response to COVID-19 in Indonesia (As of 4 May 2021) Format As of 4 May 2021, the Indonesian Government has announced 1,686,373 confirmed cases of COVID-19 in all 34 provinces of Indonesia, with 99,087 active cases, 46,137 deaths, and 1,541,149 people that have recovered from the illness. The government has also reported 77,804 suspected cases. With the arrival of its second shipment of the AstraZeneca vaccine containing 3.8 million doses on 26 April, Indonesia has received a total of 4.9 million doses of the vaccine. Subsequent shipments under the terms of the COVAX facility will depend on a number of global factors. On the occasion, the Minister of Foreign Affairs has reiterated the call for narrowing vaccine disparities among countries. On 30 April, Indonesia also received six million doses in bulk of the Sinovac Biotech vaccine, and 482,400 vial doses from the Sinopharm China National Pharmaceutical Group, obtained through purchasing agreements. Overall, the

Sulawesi selatanBantuan produktifUsaha mikroSinovac biotechSinopharm china national pharmaceutical groupMinistry of healthProductive assistance for micro enterprisesMedium enterprisesHome affairs numberNational taskMinistry of cooperativesForeign affairsIndonesian governmentNational task forceProductive assistanceMicro enterprises